Iron Deficiency Anaemia: Clinical Trials

19 trials for Iron Deficiency Anaemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 2 not yet recruiting, 1 enrolling by invitation, 1 recruiting. 10 Phase 3, 4 Not applicable, 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 10
Not applicable4Completed 2, Not yet recruiting 1, Recruiting 1
Early Phase 11Completed 1
Phase 21Completed 1

Follow Iron Deficiency Anaemia: new trials by email Literature Review of Iron Deficiency Anaemia trials Research Report on Iron Deficiency Anaemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Blood Flow Restriction and Aerobic Exercise in Iron Deficiency Anemia
aerobic exercise + blood flow restriction, aerobic exercise - Iron Deficiency Anaemia
Not applicableNot yet recruitingCairo University502026-07-252026-07-14
The Use of Robot Assisted Magnetically Controlled Capsule Endoscopy in Patients With Iron Deficiency Anaemia
Robot assisted magnetically controlled capsule endoscopy - Iron Deficiency Anaemia
Not applicableRecruitingUniversity of Edinburgh1002026-05-112026-05-14
Questionnaire About Risk Factors of Iron Deficiency Anemia in Pregnancy
Iron Deficiency Anaemia
Not yet recruitingAssiut University2002025-02-012025-01-07
Iron-deficiency Anaemia and Its Impact on Recovery After Colorectal Cancer Surgery
Laboratory analyses for the detection of iron deficiency anaemia - Iron Deficiencies, Iron Deficiency Anaemia
Enrolling by invitationOncology Institute of Vojvodina2002024-06-032025-06-04
Assessing the Effect of a Mineral-enriched Powder on Iron Deficiency in Women of Reproductive Age
Mineral-enriched powder, Placebo powder - Iron Deficiency, Iron Deficiency Anaemia
Phase 2CompletedCarleton University1502023-04-272026-04-27
Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease
Ferric Maltol, Placebo Oral Capsule - Iron Deficiency Anaemia
Phase 3CompletedJiangsu Aosaikang Pharmaceutical Co., Ltd.1222021-09-012026-07-31
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
Iron isomaltoside/ferric derisomaltose, Ferric carboxymaltose - Iron Deficiency Anaemia, Iron Deficiency Anemia
Phase 3CompletedPharmacosmos A/S1222017-10-302020-02-25
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
Iron isomaltoside/ferric derisomaltose, Ferric carboxymaltose - Iron Deficiency Anaemia, Iron Deficiency Anemia
Phase 3CompletedPharmacosmos A/S1232017-10-242020-02-25
An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)
Iron isomaltoside/ferric derisomaltose - Iron Deficiency Anemia, Iron Deficiency Anaemia
Phase 3CompletedPharmacosmos A/S1032017-01-092020-03-10
Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
Iron isomaltoside/ferric derisomaltose, Iron sucrose - Iron Deficiency Anaemia, Iron Deficiency Anemia
Phase 3CompletedPharmacosmos A/S15382016-11-292020-10-06
Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)
Iron isomaltoside/ferric derisomaltose, Iron sucrose - Iron Deficiency Anaemia, Iron Deficiency Anemia
Phase 3CompletedPharmacosmos A/S15122016-11-082020-10-06
Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)
10% Iron Isomaltoside 1000 - Iron Deficiency Anaemia
CompletedPharmacosmos UK Ltd3592016-01-222019-05-23
European Novel Motorized Spiral Endoscopy Trial
motorized spiral enteroscopy - Disorder of Small Intestine, Gastrointestinal Hemorrhage
Not applicableCompletedEvangelisches Krankenhaus Düsseldorf1362015-11-012018-02-14
IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose
iron isomaltoside 1000 (Monofer®), iron sucrose (Venofer®) - Iron Deficiency Anaemia
Phase 3CompletedPharmacosmos A/S5112014-05-012018-09-27
Zambia Micronutrient Powder Trial Effectiveness Study
Micronutrient Powders - Iron Deficiency Anaemia, Stunting
Not applicableCompletedUniversity of British Columbia6312013-06-012015-06-04
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)
ST10, Placebo oral capsule - Iron Deficiency Anaemia, Inflammatory Bowel Disease
Phase 3CompletedShield Therapeutics1282011-08-012020-10-30
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
ST10-021, Placebo Comparator - Iron Deficiency Anaemia, Inflammatory Bowel Disease
Phase 3CompletedShield Therapeutics1282011-08-012020-10-30
Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
FCM (Ferric carboxymaltose) high ferritin target, FCM (Ferric carboxymaltose) low ferritin target, Oral Iron (Ferrous sulphate) - Iron Deficiency Anaemia, Chronic Kidney Disease
Phase 3CompletedVifor Pharma6262009-12-012014-05-20
A Pilot Study to Assess the Influence of Dietary Organic Acids on Iron Absorption.
ferrous sulphate, ferric iron oxide-organic acid (Fe-OA) - Iron Deficiency Anaemia
Early Phase 1CompletedMedical Research Council712006-05-012013-11-25

Narrower conditions

Anemia, Iron-Deficiency (19)  ·  Iron Deficiencies (8)  ·  Anemia (4)  ·  Inflammatory Bowel Diseases (3)  ·  Renal Insufficiency, Chronic (3)  ·  Crohn Disease (2)  ·  Hypophosphatemia (2)  ·  Celiac Disease (1)  ·  Colitis, Ulcerative (1)  ·  Colorectal Neoplasms (1)  ·  Fatigue (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Growth Disorders (1)  ·  Kidney Diseases (1)  ·  Postoperative Complications (1)

Broader conditions

Anemia, Hypochromic (19)  ·  Hematologic Diseases (19)  ·  Hemic and Lymphatic Diseases (19)  ·  Iron Metabolism Disorders (19)  ·  Metabolic Diseases (19)  ·  Nutritional and Metabolic Diseases (19)  ·  Anemia (15)  ·  Iron Deficiencies (11)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Pathologic Processes (6)  ·  Digestive System Diseases (5)  ·  Gastrointestinal Diseases (5)  ·  Intestinal Diseases (5)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)

Interventions

iron isomaltoside 1000 (7)  ·  ferric derisomaltose (5)  ·  Ferric Oxide, Saccharated (3)  ·  ferric carboxymaltose (3)  ·  ferric maltol (3)  ·  ferric trimaltol (2)  ·  ferrous sulfate (2)  ·  Endoscopy (1)  ·  Exercise (1)  ·  Fosfomycin (1)  ·  Iron (1)

Sponsors

Pharmacosmos A/S (6)  ·  Shield Therapeutics (2)  ·  Assiut University (1)  ·  Cairo University (1)  ·  Carleton University (1)  ·  Evangelisches Krankenhaus Düsseldorf (1)  ·  Jiangsu Aosaikang Pharmaceutical Co., Ltd. (1)  ·  Medical Research Council (1)  ·  Oncology Institute of Vojvodina (1)  ·  Pharmacosmos UK Ltd (1)  ·  University of British Columbia (1)  ·  University of Edinburgh (1)  ·  Vifor Pharma (1)

Countries

United States (7)  ·  United Kingdom (4)  ·  Belgium (2)  ·  Germany (2)  ·  Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Greece (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)

Top investigators

Nicholas Mallard, PhD (2)  ·  Agnes Aongola (1)  ·  Horst Neuhaus, MD (1)  ·  Iain Macdougall (1)  ·  Jason Moore, BMedSci, BMBS, FRCP (1)  ·  John N Plevris, MD, DM, PhD(E), FRCPE, FEBGH (1)  ·  Jonathan Powell, PhD (1)  ·  Kristin Connor, PhD (1)  ·  Sylvia Simon, PhD (1)

Results publications

PMID 25545376, PMID 27237709, PMID 32016310, PMID 24891437, PMID 28095881, PMID 28339831, PMID 31243803, PMID 32049331, PMID 32332141, PMID 33302891